Jacobs Levy Equity Management Portfolio holdings

Jacobs Levy Equity Management's Q2 2017 Portfolio in Review

As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.

• Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
• Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
• Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
• Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
• Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
• Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
• Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.